Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: Long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Objective: To investigate long-term prognostic importance of newly discovered glucose disturbances in patients with acute myocardial infarction (AMI). Methods: During 1998–2001, consecutive patients with AMI (n = 167) and healthy controls (n = 184) with no previously known diabetes were investigated with an oral glucose tolerance test (OGTT). Patients and controls were separately followed up for cardiovascular events (first of cardiovascular mortality/AMI/stroke/heart failure) during a decade. Results: In all, 68% of the patients and 35% of the controls had newly detected abnormal glucose tolerance (AGT). Cardiovascular event (n = 72, p = 0.0019) and cardiovascular mortality (n = 31, p = 0.031) were more frequent in patients with newly detected AGT. Regarding patients, a Cox proportional-hazard regression analysis identified AGT (hazard ratio (HR): 2.30; 95% confidence interval (CI): 1.24–4.25; p = 0.008) and previous AMI (HR: 2.39; CI: 1.31–4.35; p = 0.004) as prognostically important. Conclusion: An OGTT at discharge after AMI disclosed a high proportion of patients with previously unknown AGT which had a significant and independent association with long-term prognosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetes is regarded as an independent risk factor of early and late mortality.”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [432]
Citations
Cites
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
International Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht108 · Cited by 1,955
Self-citationFox, K. A. A., Dabbous, O. H., Goldberg, R. J., Pieper, K. S., Eagle, K. A., Van de Werf, F., Avezum, Á., Goodman, S. G., Flather, M. D., Anderson, F. A., et al. (2006) · BMJ · doi:10.1136/bmj.38985.646481.55 · Cited by 1,693
Coutinho, M., Gerstein, H. C., Wang, Y., & Yusuf, S. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.233 · Cited by 1,685 · cited 1×
“Total mortality 28 (15) 13 (11) 11 (24) 4 (20) Cardiovascular death 12 (7) 4 (3) 5 (11) 3 (15) Cancer death 11 (6) 7 (6) 3 (7) 1 (5) Miscellaneous deathc 5 (3) 2 (2) 3 (7) 0 (0) Non-fatal stroke 7 (4) 3 (3) 3 (7) 1 (5) Non-fatal myocardial infarction 10 (5) 6 (5) 2 (4) 2 (10) Severe heart failure 6 (3) 4 (3) 1 (2) 1 (…”
Norhammar, A., Tenerz, Å., Nilsson, G., Hamsten, A., Efendíc, S., Rydén, L., & Malmberg, K. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09089-x · Cited by 1,112 · cited 1×
“Total mortality 53 (32) 14 (26) 21 (36) 18 (33) Cardiovascular death 31 (19) 5 (9) 14 (25) 12 (22) Cancer death 15 (9) 9 (17) 3 (5) 3 (5) Miscellaneous deathc 6 (4) 0 (0) 3 (5) 3 (5) Non-fatal stroke 14 (8) 3 (6) 7 (12) 4 (7) Non-fatal myocardial infarction 31 (19) 5 (9) 15 (26) 11 (20) Severe heart failure 23 (14) 3…”
Self-citationPrimary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
Hoelzel, W., Weykamp, C., Jeppsson, J.-O., Miedema, K., Barr, J. R., Goodall, I., Hoshino, T., John, W. G., Kobold, U., Little, R., et al. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.024802 · Cited by 690 · cited 2×
“Total mortality 53 (32) 14 (26) 21 (36) 18 (33) Cardiovascular death 31 (19) 5 (9) 14 (25) 12 (22) Cancer death 15 (9) 9 (17) 3 (5) 3 (5) Miscellaneous deathc 6 (4) 0 (0) 3 (5) 3 (5) Non-fatal stroke 14 (8) 3 (6) 7 (12) 4 (7) Non-fatal myocardial infarction 31 (19) 5 (9) 15 (26) 11 (20) Severe heart failure 23 (14) 3…”
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179294 · Cited by 638
BARTNIK, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.027 · Cited by 617 · cited 2×
“003 Hyperlipidaemia (treated) 8 (7) 6 (9) 0.”
The DECODE Study Group, & on behalf of the European Diabetes Epidemiology Group (2003) · Diabetes Care · doi:10.2337/diacare.26.3.688 · Cited by 516
The National Survey of Stroke. Clinical findings.
Walker, A., Robins, M., & Weinfeld, F. D. (1981) · PubMed · Cited by 460
Mooy, J. M., Grootenhuis, P. A., de Vries, H., Kostense, P. J., Popp-Snijders, C., Bouter, L. M., & Heine, R. J. (1996) · Diabetologia · doi:10.1007/bf00418345 · Cited by 344 · cited 1×
“Total mortality 53 (32) 14 (26) 21 (36) 18 (33) Cardiovascular death 31 (19) 5 (9) 14 (25) 12 (22) Cancer death 15 (9) 9 (17) 3 (5) 3 (5) Miscellaneous deathc 6 (4) 0 (0) 3 (5) 3 (5) Non-fatal stroke 14 (8) 3 (6) 7 (12) 4 (7) Non-fatal myocardial infarction 31 (19) 5 (9) 15 (26) 11 (20) Severe heart failure 23 (14) 3…”
BARTNIK, M., MALMBERG, K., NORHAMMAR, A., TENERZ, A., OHRVIK, J., & RYDEN, L. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.09.021 · Cited by 281 · cited 1×
“Total mortality 28 (15) 13 (11) 11 (24) 4 (20) Cardiovascular death 12 (7) 4 (3) 5 (11) 3 (15) Cancer death 11 (6) 7 (6) 3 (7) 1 (5) Miscellaneous deathc 5 (3) 2 (2) 3 (7) 0 (0) Non-fatal stroke 7 (4) 3 (3) 3 (7) 1 (5) Non-fatal myocardial infarction 10 (5) 6 (5) 2 (4) 2 (10) Severe heart failure 6 (3) 4 (3) 1 (2) 1 (…”
Self-citationBasu, S., Senior, R., Raftery, E. B., & Lahiri, A. (1996) · European Heart Journal · doi:10.1093/eurheartj/17.suppl_f.43 · Cited by 188
Hu, D.-Y., Pan, C.-Y., Yu, J.-M., & for the China Heart Survey Group (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl207 · Cited by 166 · cited 1×
“Total mortality 28 (15) 13 (11) 11 (24) 4 (20) Cardiovascular death 12 (7) 4 (3) 5 (11) 3 (15) Cancer death 11 (6) 7 (6) 3 (7) 1 (5) Miscellaneous deathc 5 (3) 2 (2) 3 (7) 0 (0) Non-fatal stroke 7 (4) 3 (3) 3 (7) 1 (5) Non-fatal myocardial infarction 10 (5) 6 (5) 2 (4) 2 (10) Severe heart failure 6 (3) 4 (3) 1 (2) 1 (…”
Lenzen, M., Ryden, L., Ohrvik, J., Bartnik, M., Malmberg, K., Scholte op Reimer, W., Simoons, M. L., & on behalf of the Euro Heart Survey Investigators (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl363 · Cited by 164
Self-citationNing, F., Tuomilehto, J., Pyörälä, K., Onat, A., Söderberg, S., Qiao, Q., & for the DECODE Study Group (2010) · Diabetes Care · doi:10.2337/dc09-2328 · Cited by 140
Bartnik, M., Malmberg, K., Hamsten, A., Efendic, S., Norhammar, A., Silveira, A., Tenerz, Å., Öhrvik, J., & Rydén, L. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01371.x · Cited by 112 · cited 1×
“Total mortality 53 (32) 14 (26) 21 (36) 18 (33) Cardiovascular death 31 (19) 5 (9) 14 (25) 12 (22) Cancer death 15 (9) 9 (17) 3 (5) 3 (5) Miscellaneous deathc 6 (4) 0 (0) 3 (5) 3 (5) Non-fatal stroke 14 (8) 3 (6) 7 (12) 4 (7) Non-fatal myocardial infarction 31 (19) 5 (9) 15 (26) 11 (20) Severe heart failure 23 (14) 3…”
Self-citationWallander, M., Malmberg, K., Norhammar, A., Rydén, L., & Tenerz, A. (2008) · Diabetes Care · doi:10.2337/dc07-1552 · Cited by 91
Self-citationKnudsen, E. C., Seljeflot, I., Abdelnoor, M., Eritsland, J., Mangschau, A., Arnesen, H., & Andersen, G. Ø. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-6 · Cited by 84
Wallander, M., Bartnik, M., Efendić, S., Hamsten, A., Malmberg, K., Öhrvik, J., Rydén, L., Silveira, A. M. V., & Norhammar, A. (2005) · Diabetologia · doi:10.1007/s00125-005-1931-z · Cited by 80 · cited 2×
“911 Family history of CHD 35 (29) 16 (25) 0.”
Self-citationDoerr, R., Hoffmann, U., Otter, W., Heinemann, L., Hunger-Battefeld, W., Kulzer, B., Klinge, A., Lodwig, V., Amann-Zalán, I., Sturm, D., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2253-y · Cited by 72 · cited 5×
“One patient and one control were lost to follow-up, and 13 patients were not investigated with an OGTT at discharge11 due to death during hospitalisation (2), refusal (2), illness (7) or technical problems (2) leaving 167 classified patients (4 patients had overt diabetes according to several fasting glucose levels an…”
MethodInfluentialCapillary Blood on Filter Paper for Determination of HbA1c by Ion Exchange Chromatography
Jeppsson, J.-O., Jerntorp, P., Almër, L.-O., Persson, R., Ekberg, G., & Sundkvist, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.2.142 · Cited by 70 · cited 1×
“Total mortality 28 (15) 13 (11) 11 (24) 4 (20) Cardiovascular death 12 (7) 4 (3) 5 (11) 3 (15) Cancer death 11 (6) 7 (6) 3 (7) 1 (5) Miscellaneous deathc 5 (3) 2 (2) 3 (7) 0 (0) Non-fatal stroke 7 (4) 3 (3) 3 (7) 1 (5) Non-fatal myocardial infarction 10 (5) 6 (5) 2 (4) 2 (10) Severe heart failure 6 (3) 4 (3) 1 (2) 1 (…”
Tamita, K., Katayama, M., Takagi, T., Akasaka, T., Yamamuro, A., Kaji, S., Morioka, S., & Kihara, Y. (2007) · Circulation Journal · doi:10.1253/circj.71.834 · Cited by 52 · cited 1×
“715 Myocardial infarction 7 (13) 25 (22) 0.”
de Mulder, M., Oemrawsingh, R. M., Stam, F., Boersma, E., & Umans, V. A. (2012) · Heart · doi:10.1136/heartjnl-2011-300163 · Cited by 46 · cited 2×
“Total mortality 53 (32) 14 (26) 21 (36) 18 (33) Cardiovascular death 31 (19) 5 (9) 14 (25) 12 (22) Cancer death 15 (9) 9 (17) 3 (5) 3 (5) Miscellaneous deathc 6 (4) 0 (0) 3 (5) 3 (5) Non-fatal stroke 14 (8) 3 (6) 7 (12) 4 (7) Non-fatal myocardial infarction 31 (19) 5 (9) 15 (26) 11 (20) Severe heart failure 23 (14) 3…”
Anderson, R. E., Brismar, K., & Ivert, T. (2007) · Diabetes and Vascular Disease Research · doi:10.3132/dvdr.2007.028 · Cited by 18 · cited 1×
“Total mortality 53 (32) 14 (26) 21 (36) 18 (33) Cardiovascular death 31 (19) 5 (9) 14 (25) 12 (22) Cancer death 15 (9) 9 (17) 3 (5) 3 (5) Miscellaneous deathc 6 (4) 0 (0) 3 (5) 3 (5) Non-fatal stroke 14 (8) 3 (6) 7 (12) 4 (7) Non-fatal myocardial infarction 31 (19) 5 (9) 15 (26) 11 (20) Severe heart failure 23 (14) 3…”
Research works printed but not linked: 2
- The Task Force on the Management of Acute Myocardial infarction of the European Society of Cardiology, 1996, Eur Heart J, 17, 43
- Walker AE, 1981, Stroke, 12, I13
Cited by
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad191 · Cited by 5,333
Cosentino, F., Grant, P. J., Aboyans, V., Bailey, C. J., Ceriello, A., Delgado, V., Federici, M., Filippatos, G., Grobbee, D. E., Hansen, T. B., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz486 · Cited by 4,763
Self-citation2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Self-citationHolman, R. R., Coleman, R. L., Chan, J. C. N., Chiasson, J.-L., Feng, H., Ge, J., Gerstein, H. C., Gray, R., Huo, Y., Lang, Z., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30309-1 · Cited by 323
Self-citation2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rossello, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G.-A., Dweck, M. R., Galbraith, M., et al. (2024) · European Heart Journal: Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 314
Metadata
- Authors
- Ritsinger, V., Tanoglidi, E., Malmberg, K., Näsman, P., Rydén, L., Tenerz, Å., & Norhammar, A.
- Affiliations
- Karolinska Institutet (SE)
- Västerås Municipality (SE)
- KTH Royal Institute of Technology (SE)
- Venue
- Diabetes and Vascular Disease Research
- Publisher
- SAGE Publications
- Published
- 2014-10-13
- Volume
- 12
- Issue
- 1
- Pages
- 23-32
- ISSN
- 1479-1641 (ISSN-L)
- 1752-8984
- OpenAlex
- W2146618237
- Cited by
- 71
- References
- 30
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 7 · 2023: 6 · 2022: 9 · 2021: 10 · 2020: 6 · 2019: 9 · 2018: 6 · 2017: 6 · 2016: 3 · 2015: 1
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Diabetes and Vascular Disease Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- AFA Försäkring
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- acute myocardial infarction, impaired glucose tolerance, oral glucose tolerance test, cardiovascular mortality, cardiovascular events, prognosis, diabetes screening, heart failure, stroke
- MeSH terms
- Aged, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Glucose Tolerance Test, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Patient Discharge, Prognosis, Prospective Studies, Recurrence, Risk Factors, Sweden, Cohort Studies, Prevalence, Survival Analysis, Glucose Intolerance, Diabetic Cardiomyopathies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.